Aerosol powder formulation comprising sieved lactose

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/4375 (2006.01) A61K 9/12 (2006.01) A61K 9/72 (2006.01)

Patent

CA 2623882

This invention relates to dry power aerosol formulations for use with a dry powder inhaler, the formulation comprising the PDE 4 inhibitor N-cyclopropyl-1- [3-(1-oxido-3-pyridinylethynyl)phenyl]-1,4-dihydro[1,8] naphthyridin-4-one-3- carboxamide (Formula I), and sieved lactose for inhalation.

Cette invention concerne des formulations aérosols de poudre sèche destinées à être utilisées avec un inhalateur de poudre sèche, la formulation comprenant l'inhibiteur de PDE 4 N-cyclopropyl-1-[3-(1-oxydo-3-pyridinyléthynyl)phényl]-1,4-dihydro[1,8] naphthyridin-4-one-3-carboxamide (Formule I), et un lactose tamisé pour inhalation.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Aerosol powder formulation comprising sieved lactose does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aerosol powder formulation comprising sieved lactose, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aerosol powder formulation comprising sieved lactose will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1807739

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.